About This Fund
The SOSV V fund is focused on deep tech startups in human and planetary health, with a focus on decarbonization and re-industrialization. The fund will invest in startups in the health sector, ranging from therapeutics to medical devices, as well as companies working on climate change solutions. SOSV operates startup program facilities in New York City, Newark, and San Francisco, supporting about 80 startups per year. The fund's limited partners include corporates, sovereign wealth funds, institutional investors, and private family offices around the world. The fund closed at $306 million on April 16th, 2024. SOSV invests starting at the pre-seed stage and continues through series seed, A, and later stages, resulting in about 200 investments per year. The fund tracks top portfolio startups in its annual Climate Tech 100 and Human Health 100 lists, which include companies working on climate solutions and health-related technologies. The fund also invests in facilities and equipment to help deep tech founders develop and de-risk their technologies. It operates in 40 countries and has founders representing 75 nationalities. The portfolio includes startups with 33% of companies having at least one female founder. The fund partners with other co-investors and has received support from venture firms and early-stage investors who have contributed to the successful launch of startups. The fund's emphasis on decarbonization and re-industrialization highlights its commitment to addressing climate change and creating positive change for humanity. The fund aims to bring power and expertise to the fight against climate-driven issues and loss of life.